Clinical Trial Update: Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042) [Phase 3]

View source ↗

Summary

A Phase 3 trial (MK-7264-042) evaluating gefapixant in women with chronic cough and stress urinary incontinence has completed and posted efficacy and safety res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough
• Stress Urinary Incontinence

Drugs mentioned

• Gefapixant (gefapixant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Cough | Phase 3 | Status: COMPLETED | Results posted: 2023-09-22